Allscripts Healthcare Solutions (MDRX) Lowered to Hold at BidaskClub

Allscripts Healthcare Solutions (NASDAQ:MDRX) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday.

A number of other research firms also recently issued reports on MDRX. Zacks Investment Research restated a “hold” rating on shares of Allscripts Healthcare Solutions in a research note on Monday, December 31st. SunTrust Banks downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Friday, November 2nd. Robert W. Baird dropped their price target on Allscripts Healthcare Solutions from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Friday, November 2nd. ValuEngine downgraded Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Friday, November 2nd. Finally, Citigroup dropped their price target on Allscripts Healthcare Solutions from $19.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, November 2nd. Eight research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $14.35.

NASDAQ:MDRX opened at $10.60 on Friday. The company has a market cap of $2.09 billion, a P/E ratio of 22.55, a PEG ratio of 1.80 and a beta of 1.40. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 1.61. Allscripts Healthcare Solutions has a 52-week low of $8.54 and a 52-week high of $14.97.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, February 21st. The software maker reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.01). The firm had revenue of $538.00 million for the quarter, compared to analysts’ expectations of $565.52 million. Allscripts Healthcare Solutions had a positive return on equity of 8.25% and a negative net margin of 0.25%. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.18 EPS. On average, research analysts expect that Allscripts Healthcare Solutions will post 0.54 EPS for the current fiscal year.

In other Allscripts Healthcare Solutions news, insider Brian Farley sold 6,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, January 18th. The stock was sold at an average price of $12.00, for a total value of $72,000.00. Following the transaction, the insider now directly owns 235,673 shares in the company, valued at approximately $2,828,076. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Richard J. Poulton sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Thursday, December 13th. The shares were sold at an average price of $9.82, for a total value of $589,200.00. Following the completion of the transaction, the president now owns 479,520 shares in the company, valued at $4,708,886.40. The disclosure for this sale can be found here. Insiders acquired a total of 37,728 shares of company stock worth $380,972 over the last quarter. Company insiders own 1.10% of the company’s stock.

Several hedge funds have recently made changes to their positions in MDRX. First Trust Advisors LP grew its stake in shares of Allscripts Healthcare Solutions by 129.5% in the 3rd quarter. First Trust Advisors LP now owns 143,024 shares of the software maker’s stock valued at $2,038,000 after purchasing an additional 80,698 shares during the last quarter. Creative Planning lifted its holdings in shares of Allscripts Healthcare Solutions by 53.5% in the 3rd quarter. Creative Planning now owns 36,293 shares of the software maker’s stock valued at $517,000 after buying an additional 12,650 shares during the period. Russell Investments Group Ltd. lifted its holdings in shares of Allscripts Healthcare Solutions by 3.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,351,204 shares of the software maker’s stock valued at $19,252,000 after buying an additional 44,159 shares during the period. CWM LLC lifted its holdings in shares of Allscripts Healthcare Solutions by 33.8% in the 3rd quarter. CWM LLC now owns 230,869 shares of the software maker’s stock valued at $3,290,000 after buying an additional 58,323 shares during the period. Finally, North Star Asset Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 1.6% in the 3rd quarter. North Star Asset Management Inc. now owns 639,823 shares of the software maker’s stock valued at $9,117,000 after buying an additional 9,920 shares during the period.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Article: Cost of Equity

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.